Sample Collections From the Airways of Asthmatic Patients
NCT00001888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 574
Last updated 2026-05-22
Summary
Fiberoptic bronchoscopy is a procedure which involves passing a pencil-thin tube into the lung in order to collect fluid and cells from the airways. Fiberoptic bronchoscopy can collect cells from the walls of airways by gently brushing them (bronchial brushing). In addition, squirting small amounts of sterile water in to the airway and gently suctioning it back into the bronchoscope (bronchoalveolar lavage) collects cells.
In this study, researchers plan to perform these tests on patients with asthma and normal volunteers. This research may help to improve the understanding of the processes involved in airway inflammation and asthma.
Conditions
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Amisha V Barochia, M.D. · National Heart, Lung, and Blood Institute (NHLBI)
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-06-02
Countries
- United States
Study Locations
More Related Trials
-
Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects
NCT00331058 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
NCT01370317 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of Home Spirometry in the Monitoring of Patients With Acute Exacerbation of Asthma
NCT05603494 ·Status: UNKNOWN ·Phase: NA
-
Induced Sputum Study (0000-065)
NCT00623714 ·Status: COMPLETED ·Phase: PHASE1
-
Measurements of Inflammation Induced by Allergen Inhalation Challenge in Mild Allergic Asthma
NCT06411886 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma
NCT05850494 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma
NCT02740049 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
A 12-Week Study in Adult Subjects With Asthma
NCT01516086 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Novel Procedure for Methacholine Challenge Testing
NCT02965482 ·Status: COMPLETED ·Phase: NA
-
Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma
NCT00980707 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase Ib Study of RC1416 Injection
NCT06911866 ·Status: COMPLETED ·Phase: PHASE1
-
Strategies to Improve Asthma and Treatment of Asthma in Canadians
NCT01525381 ·Status: COMPLETED
-
Single Dose Study of GSK1440115 in Patients With Asthma
NCT01424280 ·Status: COMPLETED ·Phase: PHASE1
-
In-exsufflator Cough Assist Device in Patients With Symptomatic Bronchiectasis
NCT00452114 ·Status: TERMINATED ·Phase: NA
-
Saline Challenge in Monitoring Asthma Control
NCT00859274 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial of Soluble Fiber for Asthma
NCT06372249 ·Status: RECRUITING ·Phase: PHASE2
-
Imaging Study of the Lungs During an Allergic Asthma Attack
NCT01547286 ·Status: COMPLETED ·Phase: NA
-
Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics
NCT01420003 ·Status: COMPLETED ·Phase: NA
-
Reversibility of Methacholine Induced Bronchoconstriction
NCT05977699 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma
NCT00658749 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-ranging Study of Fluticasone Furoate (FF)
NCT01563029 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma
NCT01687283 ·Status: COMPLETED ·Phase: PHASE3